Clinical Trials Directory

Trials / Completed

CompletedNCT01226368

Epidemiology of Papillomavirus Infection (HPV) on Infected Women by Human Immunodeficience Virus (HIV) in West Indies and French Guiana.

Status
Completed
Phase
Study type
Observational
Enrollment
455 (actual)
Sponsor
University Hospital Center of Martinique · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Cervical cancer is a public health problem. In term of frequency and mortality, it represents in Martinique the third localization the most frequently diagnosed and the fifth cause of death by cancer. Cervical cancer is recognized as viro-inducted. Human papillomavirus (HPV) is the etiologic agent, as a necessary but not sufficient cause, in the cancer genesis. It is estimated than about 70 to 80% of women have been or will be infected with an HPV in their genital life, the risks factors being those of the others sexually transmitted diseases (STD). Most of HPV infection are transient, by spontaneous clearance in a few months of the virus under episomal form. Carcinogen risk is related to viral persistency which inducts the condition of cellular transformation. Infection persistency and subsequent carcinogen risk depend of the genotype concerned and of the host immunitary response. HIV infection is known to be associated with an higher prevalency of one or several infection with HPV-HR. However, no data about HIV/HPV coinfection prevalency are available nowadays in French overseas department of South America whereas they are the most affected by HIV.

Conditions

Interventions

TypeNameDescription
OTHERBiological Sample collectionCervix cells

Timeline

Start date
2010-12-01
Primary completion
2011-01-01
Completion
2014-03-01
First posted
2010-10-22
Last updated
2014-10-30

Locations

1 site across 1 country: Martinique

Source: ClinicalTrials.gov record NCT01226368. Inclusion in this directory is not an endorsement.